YAP1 and metabolic dysfunction-associated steatohepatitis: Restoration of YAP expression by lysophosphatidic acid (LPA) treatment attenuated steatohepatitis in Nrf2M-KO mice with NASH and was associated with decreased NLRP3 activation in macrophages isolated from mouse livers.